These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14963998)

  • 1. [From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fast to the blood pressure goal. Lengthy dose adjustments harm compliance].
    MMW Fortschr Med; 2003 Sep; 145(39):53. PubMed ID: 14649079
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
    Chrysant SG; Weber MA; Wang AC; Hinman DJ
    Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tribenzor for hypertension.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension. Guidelines recommend fixed combinations].
    MMW Fortschr Med; 2014 Apr; 156(7):62-3. PubMed ID: 24956662
    [No Abstract]   [Full Text] [Related]  

  • 7. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
    MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
    [No Abstract]   [Full Text] [Related]  

  • 8. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM; Heagerty A; Laeis P
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
    Prescrire Int; 2011 Mar; 20(114):67. PubMed ID: 21648225
    [No Abstract]   [Full Text] [Related]  

  • 11. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
    [No Abstract]   [Full Text] [Related]  

  • 12. Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
    Rosenbaum D; Girerd X
    Curr Med Res Opin; 2012 Feb; 28(2):179-86. PubMed ID: 22114906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fast and strong lowering of pressure. The newest sartan has passed the practice test].
    MMW Fortschr Med; 2003 Oct; 145(44):45. PubMed ID: 14655509
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
    [No Abstract]   [Full Text] [Related]  

  • 18. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension.
    Karlson BW; Zetterstrand S; Olofsson B; Elmfeldt D
    Blood Press; 2009; 18(3):149-56. PubMed ID: 19462314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
    Kereiakes DJ; Maa JF; Shojaee A; Dubiel R
    Am J Cardiovasc Drugs; 2010; 10(4):239-46. PubMed ID: 20653330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.